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Life on Earth has evolved in an often hostile environment,
leading organisms to develop multiple protective mecha-
nisms. Central among these are systems for minimizing
DNA damage and thus maintaining genomic integrity. Com-
plex enzyme systems for detecting and repairing DNA base
damage are present in prokaryotic bacteria and have been
retained throughout evolution. Nucleotide excision repair
(NER), e.g., is remarkably similar between bacterial and
human cells, and mutation in any of the major NER genes
can produce a usually fatal human disease, xeroderma pig-
mentosum (XP), with principal manifestations in the skin, the
target of environmental ultraviolet (UV) irradiation. The crit-
ical importance of maintaining genomic integrity is under-
lined by two further phenomena. First, DNA repair capacity
is induced following DNA damage, allowing organisms to
devote even more energy to DNA repair when stimulated by
environmental insult. This so-called SOS response has been
extensively studied in bacteria and a functional ortholog
was more recently well documented in mammalian cells as
well. Second, in higher organisms, additional pathways
have evolved to assure that under circumstances of irrep-
arable DNA damage, cells eliminate themselves from the
proliferative compartment and thus do not propagate
mutations.
Work in our laboratory and others has provided insights
into the mechanism by which cells in higher organisms, in-
cluding human cells, use these evolutionarily perfected
strategies for avoiding the most devastating consequence
of unrepaired DNA damage: cancer. The following sections
describe a recently elucidated key role for telomeres as well
as evidence that this innate cancer avoidance mechanism
may be harnessed for the prevention and treatment of skin
malignancies.
Telomere Structure and Function
Eukaryotic chromosomes end in telomeres, tandem repeats
of TTAGGG and its complement in all mammalian cells
(Morin, 1989; Greider, 1996). In human cells, telomeres are
initially 10–14 kb pairs in length (Harley et al, 1990) with a
single-stranded 30 overhang of approximately 100–400 bas-
es comprising tandem repeats of TTAGGG (Stewart et al,
2003). Critical shortening or absence of telomeres causes
cells to recognize their chromosome ends as double-strand
breaks (Sharpless and DePinho, 2004). Such chromosomes
then undergo fusion or otherwise manifest instability, con-
firming that one role of telomeres is to ‘‘cap’’ and protect
chromosome ends (Blackburn, 2001). The ‘‘end replication
problem,’’ DNA polymerase’s inability to replicate the final
bases on each strand prior to cell division, causes telo-
meres to shorten with each round of cell division (Levy et al,
1992). Because telomeres do not encode genes or regula-
tory sequences, the buffer zone of TTAGGG repeats
prevents loss of genetic information as cells divide. Also,
because of this progressive shortening, after approximately
60 post-natal rounds of cell division, telomeres reach a
critically short length (Harley et al, 1990), after which cells
will no longer divide, regardless of mitogenic stimulation, a
state termed proliferative senescence (Levy et al, 1992).
Thus, a second function of telomeres is to act as a biologic
clock, instructing cells either that they are young and pro-
liferative or old and non-proliferative. Work from the labo-
ratory of Titia de Lange has identified a third major role of
telomeres, the initiation of DNA damage responses, as de-
scribed below.
Telomeres are normally in a loop configuration with the
double-stranded chromosome folded back on itself (Griffith
et al, 1999) and the loop secured by insertion of the 30
overhang into the proximal double-stranded DNA where it is
held in place by binding proteins, particularly telomere re-
peat factor 2 (TRF2) (van Steensel et al, 1998). Transfection
of cells with a dominant negative TRF2 construct (TRF2DN)
removes the binding protein and opens the telomere loop,
exposing the 30 overhang that is otherwise concealed (van
Steensel et al, 1998). After linearization of the chromosome,
the 30 overhang is rapidly digested and the ATM (ataxia
telanglectasia mutated) kinase, the protein mutated in the
disease ataxia telangiectasia, is activated (Karlseder et al,
1999). ATM in turn phosphorylates (activates) the p53 tumor
suppressor protein and transcription factor (Karlseder et al,
1999). Depending on the cell type, cells then undergo
apoptosis (Karlseder et al, 1999) or enter replicative senes-
cence (van Steensel et al, 1998). Both of these behaviors
are believed to represent protective DNA damage respons-Abbreviation: pTT, thymidine dinucleotide
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es: apoptosis because it removes from the tissue cells with
extensive and presumably unrepairable DNA damage and
senescence because it prevents further proliferation of cells
at risk for malignant transformation.
Interpretation of replicative senescence, in addition to
apoptosis, as a cancer prevention mechanism arises not
only from a philosophical appreciation that non-dividing
cells cannot give rise to a malignancy (Campisi, 2001), a
condition by definition in which cell growth is dysregulated
and continues indefinitely, but also from recent observations
that acute DNA damage or overexpression of certain onco-
genes can give rise to the same senescent phenotype as
does prolonged serial passage (Serrano et al, 1997; Zhu
et al, 1998) and that apoptosis and senescence are both
mediated by DNA damage response proteins such as p53
(Campisi, 2001). In any case, both apoptosis and senes-
cence are well-documented responses of malignant cells to
cancer therapy (Schmitt, 2003).
It is thus apparent that experimental telomere loop dis-
ruption and aging (serial cell division) share a common final
pathway with acute DNA damage, such as double-strand
breaks. All three responses involve activation of phospha-
tidyl inositol-3-like kinase(s) such as ATM, the ATM-related
(ATR) kinase, or the DNA dependent-protein kinase (DNA-
PK), which in turn activate p53 and other effector proteins
(Yang et al, 2003). The final cellular response, apoptosis
versus proliferative senescence, depends on the cell type
and not on the character of the initial stimulus. These ob-
servations have led us to hypothesize that the common final
pathway begins not with activation of the kinase but rather
more proximally, with disruption of the telomere loop and
exposure of the 30 single-stranded overhang sequence, in
mammalian cells repeats of TTAGGG.
DNA Damage Responses in Skin
In human skin, the most common medically consequential
forms of DNA damage result from UV exposure. UV plays a
major role in the great majority of the more than 1.3 million
basal and squamous cell carcinomas diagnosed each year
in the US (ACS, 2004), and is implicated in more than two-
thirds of all melanomas (Gilchrest et al, 1999). In addition to
ample and/or intense intermittent sun exposure, major risk
factors for skin cancer include fair complexion, poor tanning
ability, and tendency to freckle, all indicative of vulnerability
to UV insult (Fitzpatrick and Ortonne, 2003).
It has long been recognized that UV exposure directly
damages DNA (Setlow and Carrier, 1966) and also stimu-
lates increased melanogenesis, so-called tanning (Fitzpa-
trick and Ortonne, 2003), in skin that is genetically capable
of this response (Fitzpatrick phototypes II–VI). Tanning is
also well documented to protect against acute and chronic
consequences of future UV exposures, including photo-
carcinogenesis (Fitzpatrick and Ortonne, 2003). Interesting-
ly, in intact human skin, the action spectrum for production
of UV-induced DNA damage, specifically for cyclobutane
pyrimidine dimers (CPD), the most common DNA photo-
product, is identical to the action spectrum for tanning,
peaking broadly at 300 nm, and then falling off by four to
five orders of magnitude at longer UV wavelengths (Parrish
et al, 1982; Freeman et al, 1989). This suggests a cause and
effect relationship between formation of such photoprod-
ucts and the increased melanogenesis (tanning) observed
over the subsequent 3–5 d (Gilchrest and Eller, 1999). Fur-
thermore, chemical agents and restriction enzymes known
to act exclusively by damaging DNA within cells also stim-
ulate melanogenesis (Eller et al, 1996), strongly supporting
the hypothesis that DNA damage itself plays a large role in
triggering the tanning response after UV exposure. Finally,
work by our laboratory and others demonstrated that the
rate-limiting enzyme tyrosinase is a p53-regulated gene
product (Nylander et al, 2000; Khlgatian et al, 2002) and
that UV-induced melanogenesis is greatly reduced in p53
knockout animals (Gilchrest, 2004), further supporting an
evolutionary role of tanning as a DNA damage response.
Tanning is thus a major photoprotective response of hu-
man skin to UV irradiation and is capable of decreasing
DNA damage from future exposures by absorbing UV pho-
tons (Kollias et al, 1996). Also, in the human skin, melanin is
arranged in a supranuclear cap that maximizes this DNA-
protective effect (Kobayashi et al, 1998; Byers et al, 2003).
The major form of DNA protection throughout evolution,
however, has been enzymatic repair of the damaged DNA
itself. Indeed, prokaryotic bacteria have not only an elab-
orate basal mechanism of DNA repair but also an inducible
component of repair termed the SOS response (Radman,
1974, 1975). Specifically, UV irradiation leads to the gener-
ation of single-stranded DNA fragments that contain pho-
toproducts, and this DNA forms a complex with the Rec A
protein that then cleaves a transcription repressor, increas-
ing the synthesis of approximately 20 bacterial genes that
encode DNA repair and cell survival proteins (Walker, 1984).
DNA damage thus induces protective responses that render
bacteria more resistant to subsequent damage of the same
type and hence more likely to survive in the injurious
environment.
Experiments suggesting a eukaryotic SOS-like response
have been reported sporadically since the 1970s. Using an
experimental design similar to that used to demonstrate
that prior UV irradiation of bacteria enhances their ability to
repair UV-irradiated bacteriophage, human fibroblasts UV-
irradiated 4 d prior to infection with UV-irradiated herpes
virus were shown to support viral growth approximately
twice as well as unirradiated control fibroblasts (Lytle et al,
1976). As in the earlier bacterial experiments, this implied
that the host cells had enhanced DNA repair capacity fol-
lowing UV irradiation. Others later confirmed these findings
in monkey kidney cells, using SV40 virus (Taylor et al, 1982).
Moreover, the enhanced viral DNA repair by irradiated mon-
key cells was not associated with an increased mutation
frequency, as had been observed in bacteria. Subsequently,
human fibroblasts subjected either to ionizing radiation or
UV irradiation were similarly demonstrated to have en-
hanced repair of virus DNA that had been damaged by the
same insult prior to infection (Jeeves and Rainbow, 1983,
1986), and that fibroblasts from patients with ataxia tel-
angiectasia, known to be hypersensitive to ionizing radia-
tion, did not demonstrate this enhanced viral repair (Jeeves
and Rainbow, 1986). Other investigators subsequently
showed that human cells lacking p53 or expressing a dom-
inant negative p53 also do not manifest the inducible DNA
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repair response (Rainbow et al, 1995; McKay and Rainbow,
1996; McKay et al, 1997), consistent with the known acti-
vation of p53 by ATM and its central role in NER (Banin et al,
1998). Moreover, very recent data demonstrating activation
of ATM by single-stranded DNA (Lee and Paull, 2005) were
interpreted by the investigators as ‘‘consistent with the
central role of single-stranded DNA as an evolutionary con-
served signal for DNA damage.’’ Thus, there is considerable
support for the concept that mammalian cells have induc-
ible protective DNA damage responses that are functionally
analogous and perhaps even loosely analogous in their
molecular mechanism to the bacterial SOS response, de-
spite obvious discrepancies between the eukaryotic and
prokaryotic systems.
Mimicking Telomere Disruption and
Exposure of the 30 Overhang
Wishing to test the hypothesis that DNA damage is a major
stimulus for UV-induced tanning and unable to obtain a
concentrated preparation of CPD for laboratory use, we
asked whether exposure of cultured pigment cells or intact
skin to thymidine dinucleotide (pTT), the obligatory subst-
rate for the thymine dimers that account for approximately
75% of all UV-induced DNA damage (Setlow and Carrier,
1966; Matsunaga et al, 1991), might increase melanogen-
esis in the absence of UV exposure. Both cultured human
melanocytes and intact guinea-pig skin responded to pTT
treatment with dramatic increases in melanin production,
precisely mimicking UV-induced tanning clinically and his-
tologically (Eller et al, 1994). The tanning was attributable to
increased mRNA and protein expression of tyrosinase, the
rate-limiting enzyme in melanogenesis. Subsequent studies
demonstrated that the pTT-induced tan in guinea-pig skin
was highly photoprotective and thus reproduced the func-
tional as well as clinical and histologic aspects of UV-in-
duced tanning (Gilchrest and Eller, 1999).
We then asked what signaling pathways were activated
by pTT. Initial experiments focused on p53, the Guardian of
the Genome (Lane, 1992), known to mediate many DNA
damage responses. pTT-treated human keratinocytes and
fibroblasts, transfected with a non-replicating UV-damaged
choramphenicol acetyl transferase (CAT) reporter vector
that had previously been damaged by UV irradiation, gave
rise 24 h later to more than twice the CAT activity (a measure
of vector repair) than did diluent-treated control cultures
(Eller et al, 1997). pTT-treated fibroblasts showed a 2–3-fold
increase in p53 protein levels and increased p53 activity as
detected in an electrophoretic mobility shift assay in which
p53 activation is assessed by binding to its consensus se-
quence in DNA. pTT treatment of human fibroblasts was
subsequently shown to similarly increase the protein levels
of p53, as well as several p53-regulated DNA repair en-
zymes over 3–5 d (Goukassian et al, 1999). Moreover, pTT
treatment of older adult cells increased the levels of these
proteins several fold, to the basal levels observed in new-
born fibroblasts (Goukassian et al, 2002).
Functional consequences of p53 induction and activation
could also be observed following pTT treatment, in that
survival and clonogenic capacity of pre-treated UV-irradi-
ated cells and rate of repair of CPD all increased appreci-
ably (Eller et al, 1997). In subsequent experiments, the same
CAT vector, treated with benzo[a]pyrene to induce DNA ad-
ducts rather than UV irradiated to induce CPDs, was used
and vector expression in pTT-pretreated cells was again
shown to be twice that in diluent-pre-treated controls (Ma-
eda et al, 1999). To place these results in perspective, this
CAT vector host cell reactivation assay has also been used
to quantify the impact of DNA repair rate on cancer risk in
large populations (Wei et al, 1993). Cells derived from young
adult patients with basal cell carcinoma versus age-
matched controls demonstrated a 5%–8% decrease in
ability to repair the vector, and old versus young donor cells
demonstrated a 15% decrease, differences in both cases
assumed to be causally related to their increased cancer
risk (Wei et al, 1993). In comparison, the pTT-inducible in-
creases were 100%–200% of baseline rates (Eller et al,
1997; Maeda et al, 1999).
The effect of pTT pretreatment on DNA damage repair
rates was also documented in intact guinea-pig skin by
measuring the rate of removal of photoproducts following
UV irradiation (Gilchrest and Eller, 1999). In bacteria, how-
ever, the increased rate of DNA repair during the SOS re-
sponse is accompanied by increased mutation rate (Walker,
1984). Although this can be viewed as evolutionarily bene-
ficial to bacteria, promoting environmental adaptation, mu-
tations in higher organisms such as humans pose unwanted
risks to the individual, ranging from compromised tissue
function to carcinogenesis. The low-fidelity umuC and umuD
bacterial repair enzymes induced during the SOS response
(Walker, 1984) have no known human homologs, but it was
nevertheless critical to determine whether the pTT-induced
enhanced repair capacity increases the mutation rate fol-
lowing DNA damage. Three different host cell reactivation
assays using murine cells, intact murine skin, and human
fibroblasts demonstrated a substantial reduction in mutation
rate in pTT-pre-treated cells (Hadshiew et al, 1999; Khlgatian
et al, 1999; Ruenger et al, 2002). These results are consistent
with the generally inverse relationship between DNA repair
rate and mutation rate (Moriwaki et al, 1996) and the intuitive
notion that an evolutionarily conserved inducible DNA repair
capacity would increase the probability of maintaining an
intact genome in mammalian cells repeatedly exposed to
environmental mutagens (Fig 1).
Having established that pTT induces photoprotective
tanning and increases DNA repair capacity at least in
part via the p53 signaling pathway, we asked whether
other oligonucleotides might also be effective in stimulating
these potentially therapeutic responses. We found that sev-
eral other, but certainly not all, oligonucleotides have effects
similar to pTT, often at far lower molar equivalent doses,
and that activity requires nuclear uptake, a phenomenon
that appears to depend on the presence of a 50 phos-
phate group (Hadshiew et al, 2001), as reported for cellular
uptake of other oligonucleotides (Noonberg et al, 1993).
Given the very interesting consequences of experimental
loop disruption then recently reported in the literature
(van Steensel et al, 1998; Karlseder et al, 1999) and
their substantial overlap with the observed pTT effects, we
asked whether homology to the telomere 30 overhang
might be the common feature of active oligonucleotides
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in our assay systems. This proved to be the case. All active
oligonucleotides showed greater than 50% homology
with the TTAGGG tandem repeat sequence, whereas
inactive oligonucleotides failed to meet this criterion. In
general, longer sequences (up to at least 20 nucleotides)
were more effective than shorter sequences, and the pres-
ence of cytosine (C) residues specifically reduced activity
(Hadshiew et al, 2001; Eller et al, 2002). Relative activity
among test sequences was the same in all assay systems
and did not vary with the biologic endpoint used. The
shortest effective sequence, pTT, was noted to represent
100% of one-third of the tandem repeat sequence
(Eller et al, 2002).
Our observation that telomere homolog oligonucleotides,
which we subsequently termed T-oligos (Eller et al, 2003),
specifically activate DNA damage responses is consistent
with the hypothesized common final pathway for experi-
mental telomere loop disruption, cellular senescence at the
time of critical telomere shortening, and acute DNA damage
responses (Fig 2A). Exposure of the otherwise concealed 30
overhang was known to occur following telomere loop dis-
ruption by TRF2DN (Karlseder et al, 1999), and critical telo-
mere shortening might also plausibly lead to loop disruption
as a consequence of stochastic instability of a tighter loop (Li
et al, 2003). Also, recent work has strongly suggested that,
as in experimental loop disruption, loss of the overhang ac-
companies proliferative senescence (Stewart et al, 2002),
consistent with its exposure and digestion. Although another
technique has instead failed to show overall reduction in
telomere overhang length in late-passage senescent cells,
the investigators note that loss of the overhang on a minority
of chromosome strands would not be detected but might
still be sufficient to trigger cell senescence (Chai et al, 2005).
Finally, several groups have demonstrated that telomeres
are preferentially targeted at times of acute DNA damage,
whether due, e.g., to UV exposure (Oikawa et al, 2001), oxi-
dative stress (Oikawa and Kawanishi, 1999; Kawanishi and
Oikawa, 2004), or exposure to DNA-damaging chemicals
(Kang et al, 2004). In this context, it is of interest to note that
the TTAGGG sequence contains an abundance of preferred
targets for these common DNA-damaging agents: one-third
of the sequence is TT, a preferred UV target (Setlow and
Carrier, 1966), and half of the sequence consists of G res-
idues, the preferred target for reactive oxygen species and
chemical carcinogens (Cheng et al, 1992). It is thus plausible
that preferential damage to telomeres at the time of overall
genomic damage might result in telomere disruption, as a
consequence either of introducing photoproducts, chemical
adducts, or the like, or as a consequence of attempted re-
pair of these lesions. Thus, all three conditions might be
expected to expose the TTAGGG repeat sequence, which
interestingly does not otherwise appear to occur twice con-
secutively elsewhere in the human genome (NCBI Human
Genome BLASTsearch [http:www.ncbi.nlm.nih.gov/genome],
accessed in 2004), allowing it to interact with a sensor protein
or protein complex, which in turn activates of the ATM, ATR,
and/or DNA PK kinases with subsequent DNA damage
signaling (Fig 2B).
Whether or not the hypothesized mechanism is respon-
sible, we have documented extensive parallels between
T-oligo treatment and experimental telomere loop disrup-
tion, as well as between T-oligo treatment and DNA damage
responses following UV irradiation. These include not only
tanning and cell cycle arrest but also senescence (Li et al,
2003; Gilchrest, 2004; Kosmadaki and Gilchrest, 2004) and
apoptosis (Eller et al, 2002).
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Figure 1
Consequences of the SOS response in human skin.
(A) Under basal conditions, cells in the human skin
have a relatively low DNA repair capacity (DRC) and
melanin content. An initial UV exposure (UV-1) results
in substantial immediate DNA damage (solid line). DNA
repair, as measured by removal of DNA photoprod-
ucts, has been shown to occur exponentially, with the
time for removal of 50% of initial photoproducts (T1)
determined to be approximately 24 h for thymine
dimers and 6 h for (6–4) pyrimidine pyrimidone pho-
toproducts following a physiologic UV exposure in vivo
or in vitro. Over approximately 1–3 d following the UV
exposure, however, DNA repair capacity increases up
to 2–3-fold and over 3–5 d melanin content increases
similarly, leading to a visible tan. If a second equal UV
exposure (UV-2) then occurs, much of the incident ra-
diation is absorbed by epidermal melanin, leading to
the formation of fewer DNA photoproducts, and this
lesser initial DNA damage is repaired more rapidly, with the time for repair of 50% of the damage (T2) approximately half that following the initial
exposure, as determined experimentally, due to enhanced DRC. Also, after each UV exposure, there is a concentration-dependent p53-mediated
cell cycle arrest of approximately 1–2 d during which DNA repair occurs without risk of mutation. Following the second UV exposure, however, p53
induction and activation are greater and the period of cell cycle arrest is proportionately longer, providing the cell more protected time during which
DNA repair can occur without risk of mutation. Once epidermal cells resume cycling, any remaining unrepaired damaged poses a risk of introducing
a mutation into the newly synthesized DNA strand. The risk of mutation is indicated by the hatched areas under the DNA damage curves following
the UV-1 versus UV-2 exposures and is far less in cells in which the SOS response has been induced. Eventually, in the absence of further UV
exposures, DRC and melanin content return to baseline and any subsequent exposure resembles UV-1. But, additional exposures during the period
encompassed by the SOS response (assumed to be 1–2 wk or longer, depending on the inciting UV exposure, DRC, and melanin content) are
maintained or further induced and each exposure is handled like UV-2. Hence, the existence of the SOS response implies that the pattern of UV
exposures, infrequent large exposures versus frequent smaller exposures, in addition to the total cumulative UV dose, determine the degree of
damage in surviving cells. (B) pTT or other telomere homolog oligonucleotide (T-oligo) increases DRC and melanin content in cells over the same
time course as a UV exposure or other acute DNA damage, but in the absence of DNA damage. Hence, a UV exposure several days after T-oligo
treatment is handled like a second UV exposure in the panel A scenario, with less initial DNA damage and a far lower risk of mutation due to residual
DNA damage in cells that have resumed cycling after the initial period of cell cycle arrest. Modified from Gilchrest and Eller (2001).
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Potential Clinical Applications of T-Oligos
Enhancing DNA repair after UV irradiation while reducing
the mutation rate would predict that T-oligo therapy might
reduce photocarcinogenesis. To examine this possibility, we
used the widely studied SKH1 hairless mouse engineered to
express a lacZ mutation reporter transgene and a chronic
UV irradiation protocol known to produce squamous cell
carcinomas within 6 mo (Goukassian et al, 2004). Mice with
both wild-type DNA repair capacity and mice heterozygous
for deletion of the XPC repair enzyme were used to model
the broad range of the DNA repair capacity observed in the
human population. pTT or diluent alone was applied daily to
the back for the first 5 d of each month, and then the mice
were UV irradiated 5 d per wk for the remaining 3 wk of each
month, for a total of 6 mo. The UV-irradiated mice progres-
sively developed skin tumors as expected, and at the end of
6 mo only 12% of the control vehicle-treated mice were
tumor free. Seventy-eight percent of the intermittently pTT-
treated mice, however, were tumor free. Histologic analysis
revealed both actinic keratosis-like lesions and invasive
squamous cell carcinomas, with each tumor type being
more prevalent in the vehicle-treated than in the pTT-treated
mice. There was no evidence of pTT toxicity in either the
irradiated mice or in sham-irradiated controls. Assessment
of the lac-Z/pUR288 reporter plasmid showed a decreased
mutation rate in pTT-treated versus control mice after either
a single UV exposure or after 6 mo of intermittent irradiation,
confirming the previous in vitro data (see above). These data
suggest that topical T-oligo therapy might be a valuable
adjunct to sunscreen use and sun avoidance in patients at
high risk of photocarcinogenesis.
Our initial work with T-oligos fully homologous to the 30
overhang demonstrated apoptosis in multiple established
cell lines (Eller et al, 2002), including melanoma cells. Be-
cause apoptosis is a major mechanism by which chemo-
therapeutic agents reduce tumor burden, and resistance to
apoptosis is a well-documented mechanism of treatment
resistance (Schmitt, 2003), we asked whether T-oligos might
also have a role in treating established malignancies. As a
first experimental model in which to determine whether T-
oligos can serve as an effective cancer therapy, we selected
melanoma, the most fatal of skin cancers and a malignant
cell type characterized by resistance to conventional cancer
therapy once metastasis has occurred. In preliminary ex-
periments, several human melanoma cell lines were exam-
ined and found to readily undergo apoptosis within 72–96 h
of exposure to an 11-base T-oligo (pGTTAGGGTTAG). For
further study, we selected the aggressive MM-AN line (Puri
et al, 2004) known to lack p53 and p16INK4a expression,
widely used in mouse models of melanoma and considered
to be predictive of clinical responses (Paine-Murrieta et al,
1997; Jansen et al, 1998). T-oligos were added once to
culture medium at time 0, and the cells were examined daily
for 4 d. By 96 h, two-thirds of the MM-AN cells were un-
dergoing apoptosis, mediated at least in part by the p53
homolog p73 (Eller et al, 2002). Interestingly, normal human
melanocytes responded to T-oligo only with a transient cell
cycle arrest and did not undergo apoptosis (Puri et al, 2004),
suggesting that T-oligo-induced apoptosis preferentially af-
fects malignant cells. Apoptosis of the MM-AN cells was
explained in part by marked downregulation of livin/ML-IAP,
a member of the inhibitor of apoptosis family of proteins
known to be expressed normally during embryogenesis and
inappropriately re-expressed in many melanomas, thereby
contributing to their resistance to chemotherapy-induced
apoptosis (Vucic et al, 2000; Kasof and Gomes, 2001). T-
oligo-treated MM-AN cells also showed upregulation of the
melanogenic proteins tyrosinase and TRP1, as well as
the other differentiation markers gp100 and MART1, most
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Figure 2
Hypothesized DNA damage signaling pathway fol-
lowing telomere loop disruption and exposure to the
30 overhang sequence. (A) Just as experimental telo-
mere loop disruption by dominant negative telomere re-
peat factor 2 (TRF2) construct exposes the telomere 30
overhang sequence, we hypothesize that both serial cell
division with consequent critical telomere shortening
and acute DNA damage, such as UV irradiation with in-
troduction of photoproducts, distort the telomere loop
and expose the TTAGGG repeat sequence. We further
hypothesize that in all three situations, the overhang se-
quence is recognized by a nuclear sensor protein or
protein complex (open oval) that then initiates signaling
through the ATM, ATM-related (ATR), and/or DNA de-
pendent-protein kinase (DNA-PK) kinases to activate
p53 and other effector proteins. Such intense or pro-
longed signaling results in senescence or apoptosis,
depending on cell type. (B) We have observed that
treatment of mammalian cells with oligonucleotides hav-
ing substantial or complete homology to the telomere
overhang sequence also initiates signaling through the
ATM, ATR, and/or DNA-PK kinases, presumably be-
cause these T-oligos, known to enter the nucleus, are
recognized by the same sensor protein. T-oligo treat-
ment at low dose and/or short duration results in re-
versible cell cycle arrest, often with evidence of adaptive
differentiation, such as enhanced melanogenesis in pig-
ment cells, whereas higher doses or longer duration of therapy may push cells to the same cell-type-specific biologic endpoints of apoptosis or
senescence as observed after serial cell passage, acute DNA damage, or experimental telomere loop disruption. Modified from Gilchrest (2004).
128 GILCHREST AND ELLER JID SYMPOSIUM PROCEEDINGS
prominently after 72–96 h when many of the cells had al-
ready undergone apoptosis. To determine whether these
effects could be seen in vivo, the immunocompromised
SCID mouse model was used. T-oligo dramatically reduced
tumor burden when MM-AN cells were treated either prior
to tail vein injection, in a protocol that yielded numerous
metastases in control animals, or following intralesional or
intraperitoneal injection in animals with MM-AN cells im-
planted either subcutaneously or intraperitoneally (Puri et al,
2004). Small residual tumors in the T-oligo-treated animals
contained cells undergoing apoptosis and/or showing ev-
idence of differentiation by immunostaining, whereas con-
trol tumors did not. As in the cancer prevention studies,
there was no evidence of T-oligo toxicity following either
systemic or local injection daily for up to 26 d. These data
suggest that T-oligos may provide a safe and effective novel
means of treating advanced melanoma.
Summary and Conclusions
Work in many laboratories over the past decade has es-
tablished a central role for the telomere in maintaining gen-
omic integrity. Available data may be interpreted to indicate
that telomere disruption, whether due to acute DNA dam-
age or progressive telomere shortening, is the initial event
that triggers multiple DNA damage responses. The specific
initiating event is likely exposure of the otherwise concealed
single-stranded 30 overhang, tandem repeats of TTAGGG, a
signal that can be provided to cells in the absence of DNA
damage by exogenously provided T-oligos. The ability of
T-oligo treatment to trigger SOS-like responses and/or to
cause selective apoptosis of already malignantly trans-
formed cells may provide an important new means of can-
cer prevention and treatment.
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